Trilogy Metals Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Trilogy Metals Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($42.24M) | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | ($8.59M) | Feb 17, 2026 |
| FY2025 | Nov 30, 2023 | ($14.95M) | Feb 17, 2026 |
| FY2024 | Nov 30, 2022 | ($24.26M) | Feb 14, 2025 |
| FY2023 | Nov 30, 2021 | ($21.66M) | Feb 9, 2024 |
| FY2022 | Nov 30, 2020 | $161.77M | Feb 14, 2023 |
| FY2021 | Nov 30, 2019 | ($27.91M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2018 | ($21.85M) | Feb 12, 2021 |
| FY2019 | Nov 30, 2017 | ($21.10M) | Feb 13, 2020 |
| FY2018 | Nov 30, 2016 | ($4.86M) | Feb 11, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Nov 30, 2020 | $1.07M | Feb 14, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($3.25M) | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | ($1.83M) | Feb 17, 2026 |
| FY2025 | Nov 30, 2023 | ($3.09M) | Feb 17, 2026 |
| FY2024 | Nov 30, 2022 | ($3.94M) | Feb 14, 2025 |
| FY2023 | Nov 30, 2021 | ($5.12M) | Feb 9, 2024 |
| FY2022 | Nov 30, 2020 | ($8.25M) | Feb 14, 2023 |
| FY2021 | Nov 30, 2019 | ($23.49M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2018 | ($22.07M) | Feb 12, 2021 |
| FY2019 | Nov 30, 2017 | ($15.41M) | Feb 13, 2020 |
| FY2018 | Nov 30, 2016 | ($8.69M) | Feb 11, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Nov 30, 2019 | $645.0K | Feb 11, 2022 |
| FY2020 | Nov 30, 2018 | $7.0K | Feb 12, 2021 |
| FY2019 | Nov 30, 2017 | $300.0K | Feb 13, 2020 |
| FY2018 | Nov 30, 2016 | $122.0K | Feb 11, 2019 |
| FY2017 | Nov 30, 2015 | $48.0K | Feb 2, 2018 |
| FY2016 | Nov 30, 2014 | $18.0K | Feb 3, 2017 |
| FY2015 | Nov 30, 2013 | $233.0K | Feb 8, 2016 |
| FY2014 | Nov 30, 2012 | $1.60M | Feb 6, 2015 |
| FY2013 | Nov 30, 2011 | $1.41M | Jan 30, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $157.30M | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | $133.70M | Feb 17, 2026 |
| FY2024 | Nov 30, 2023 | $138.02M | Feb 14, 2025 |
| FY2023 | Nov 30, 2022 | $146.00M | Feb 9, 2024 |
| FY2022 | Nov 30, 2021 | $167.31M | Feb 14, 2023 |
| FY2021 | Nov 30, 2020 | $185.27M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $51.62M | Feb 12, 2021 |
| FY2019 | Nov 30, 2018 | $54.66M | Feb 13, 2020 |
| FY2018 | Nov 30, 2017 | $40.28M | Feb 11, 2019 |
| FY2017 | Nov 30, 2016 | $46.75M | Feb 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $33.18M | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | $903.0K | Feb 17, 2026 |
| FY2024 | Nov 30, 2023 | $465.0K | Feb 14, 2025 |
| FY2023 | Nov 30, 2022 | $567.0K | Feb 9, 2024 |
| FY2022 | Nov 30, 2021 | $1.27M | Feb 14, 2023 |
| FY2021 | Nov 30, 2020 | $1.45M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $33.35M | Feb 12, 2021 |
| FY2019 | Nov 30, 2018 | $22.46M | Feb 13, 2020 |
| FY2018 | Nov 30, 2017 | $14.61M | Feb 11, 2019 |
| FY2017 | Nov 30, 2016 | $593.0K | Feb 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $124.12M | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | $132.79M | Feb 17, 2026 |
| FY2025 | Nov 30, 2023 | $137.56M | Feb 17, 2026 |
| FY2025 | Nov 30, 2022 | $145.43M | Feb 17, 2026 |
| FY2024 | Nov 30, 2021 | $166.04M | Feb 14, 2025 |
| FY2023 | Nov 30, 2020 | $183.81M | Feb 9, 2024 |
| FY2022 | Nov 30, 2019 | $18.26M | Feb 14, 2023 |
| FY2021 | Nov 30, 2018 | $32.20M | Feb 11, 2022 |
| FY2020 | Nov 30, 2017 | $25.67M | Feb 12, 2021 |
| FY2019 | Nov 30, 2016 | $46.15M | Feb 13, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | ($132.64M) | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | ($90.40M) | Feb 17, 2026 |
| FY2024 | Nov 30, 2023 | ($81.81M) | Feb 14, 2025 |
| FY2023 | Nov 30, 2022 | ($66.86M) | Feb 9, 2024 |
| FY2022 | Nov 30, 2021 | ($42.61M) | Feb 14, 2023 |
| FY2021 | Nov 30, 2020 | ($20.95M) | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | ($182.71M) | Feb 12, 2021 |
| FY2019 | Nov 30, 2018 | ($154.81M) | Feb 13, 2020 |
| FY2018 | Nov 30, 2017 | ($132.87M) | Feb 11, 2019 |
| FY2017 | Nov 30, 2016 | ($111.76M) | Feb 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $51.61M | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | $25.83M | Feb 17, 2026 |
| FY2024 | Nov 30, 2023 | $2.59M | Feb 14, 2025 |
| FY2021 | Nov 30, 2021 | $6.31M | Feb 11, 2022 |
| FY2021 | Nov 30, 2020 | $11.13M | Feb 11, 2022 |
| FY2020 | Nov 30, 2019 | $19.17M | Feb 12, 2021 |
| FY2020 | Nov 30, 2018 | $22.99M | Feb 12, 2021 |
| FY2020 | Nov 30, 2017 | $5.39M | Feb 12, 2021 |
| FY2019 | Nov 30, 2016 | $7.34M | Feb 13, 2020 |
| FY2017 | Nov 30, 2015 | $16.06M | Feb 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Feb 17, 2026 |
| FY2025 | Nov 30, 2023 | 0 | Feb 17, 2026 |
| FY2024 | Nov 30, 2022 | 0 | Feb 14, 2025 |
| FY2023 | Nov 30, 2021 | 0 | Feb 9, 2024 |
| FY2022 | Nov 30, 2020 | 1 | Feb 14, 2023 |
| FY2021 | Nov 30, 2019 | 0 | Feb 11, 2022 |
| FY2020 | Nov 30, 2018 | 0 | Feb 12, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Nov 30, 2024 | 0 | Feb 17, 2026 |
| FY2025 | Nov 30, 2023 | 0 | Feb 17, 2026 |
| FY2024 | Nov 30, 2022 | 0 | Feb 14, 2025 |
| FY2023 | Nov 30, 2021 | 0 | Feb 9, 2024 |
| FY2022 | Nov 30, 2020 | 1 | Feb 14, 2023 |
| FY2021 | Nov 30, 2019 | 0 | Feb 11, 2022 |
| FY2020 | Nov 30, 2018 | 0 | Feb 12, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Nov 30, 2018 | 131.59M | Feb 11, 2019 |
| FY2018 | Nov 30, 2017 | 105.68M | Feb 11, 2019 |
| FY2018 | Nov 30, 2016 | 105.29M | Feb 11, 2019 |
| FY2018 | Nov 30, 2015 | 104.80M | Feb 11, 2019 |
| FY2017 | Nov 30, 2014 | 60.30M | Feb 2, 2018 |
| FY2016 | Nov 30, 2013 | 53.07M | Feb 3, 2017 |
| FY2015 | Nov 30, 2012 | 46.67M | Feb 8, 2016 |
| FY2014 | Nov 30, 2011 | 200 | Feb 6, 2015 |
| FY2013 | Nov 30, 2010 | 0 | Jan 30, 2014 |